Annual SGA
$13.33 M
+$1.33 M+11.10%
December 31, 2023
Summary
- As of February 8, 2025, ATNM annual SGA is $13.33 million, with the most recent change of +$1.33 million (+11.10%) on December 31, 2023.
- During the last 3 years, ATNM annual SGA has risen by +$7.02 million (+111.33%).
- ATNM annual SGA is now at all-time high.
Performance
ATNM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$2.83 M
-$766.00 K-21.32%
September 30, 2024
Summary
- As of February 8, 2025, ATNM quarterly SGA is $2.83 million, with the most recent change of -$766.00 thousand (-21.32%) on September 30, 2024.
- Over the past year, ATNM quarterly SGA has increased by +$521.00 thousand (+22.59%).
- ATNM quarterly SGA is now -38.02% below its all-time high of $4.56 million, reached on June 30, 2023.
Performance
ATNM Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.41 B
-$40.91 M-2.99%
September 30, 2024
Summary
- As of February 8, 2025, ATNM TTM SGA is -$1.41 billion, with the most recent change of -$40.91 million (-2.99%) on September 30, 2024.
- Over the past year, ATNM TTM SGA has dropped by -$1.42 billion (-10681.47%).
- ATNM TTM SGA is now -727772.03% below its all-time high of -$193.80 thousand.
Performance
ATNM TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ATNM Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.1% | +22.6% | -10000.0% |
| 3 y3 years | +111.3% | +41.8% | -10000.0% |
| 5 y5 years | +98.0% | +55.2% | -10000.0% |
ATNM Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +65.0% | -38.0% | +62.9% | -43.8% | at low |
| 5 y | 5-year | at high | +141.4% | -38.0% | +145.0% | -75.7% | at low |
| alltime | all time | at high | >+9999.0% | -38.0% | -100.0% | <-9999.0% | at low |
Actinium Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.83 M(-21.3%) | $11.69 M(+0.8%) |
| Jun 2024 | - | $3.59 M(+21.3%) | $11.59 M(-7.7%) |
| Mar 2024 | - | $2.96 M(+28.4%) | $12.56 M(-5.8%) |
| Dec 2023 | $13.33 M(+11.1%) | $2.31 M(-15.5%) | $13.33 M(-11.0%) |
| Sep 2023 | - | $2.73 M(-40.2%) | $14.98 M(-2.2%) |
| Jun 2023 | - | $4.56 M(+22.1%) | $15.33 M(+9.5%) |
| Mar 2023 | - | $3.73 M(-5.6%) | $14.00 M(+16.7%) |
| Dec 2022 | $12.00 M(+48.6%) | $3.96 M(+28.8%) | $12.00 M(+12.2%) |
| Sep 2022 | - | $3.07 M(-4.9%) | $10.70 M(+11.2%) |
| Jun 2022 | - | $3.23 M(+86.3%) | $9.62 M(+18.8%) |
| Mar 2022 | - | $1.74 M(-34.7%) | $8.09 M(+0.2%) |
| Dec 2021 | $8.08 M(+28.0%) | $2.65 M(+33.1%) | $8.08 M(+11.9%) |
| Sep 2021 | - | $1.99 M(+16.6%) | $7.22 M(+2.4%) |
| Jun 2021 | - | $1.71 M(-0.5%) | $7.05 M(+8.6%) |
| Mar 2021 | - | $1.72 M(-4.3%) | $6.49 M(+2.9%) |
| Dec 2020 | $6.31 M(+14.2%) | $1.80 M(-1.6%) | $6.31 M(+9.3%) |
| Sep 2020 | - | $1.82 M(+58.1%) | $5.77 M(+0.1%) |
| Jun 2020 | - | $1.15 M(-24.7%) | $5.77 M(+1.4%) |
| Mar 2020 | - | $1.53 M(+21.6%) | $5.69 M(+3.1%) |
| Dec 2019 | $5.52 M(-18.0%) | $1.26 M(-30.8%) | $5.52 M(-0.6%) |
| Sep 2019 | - | $1.82 M(+69.3%) | $5.55 M(-2.6%) |
| Jun 2019 | - | $1.08 M(-21.1%) | $5.70 M(-8.2%) |
| Mar 2019 | - | $1.36 M(+5.5%) | $6.21 M(-7.8%) |
| Dec 2018 | $6.73 M(-26.7%) | $1.29 M(-34.4%) | $6.73 M(-4.1%) |
| Sep 2018 | - | $1.97 M(+24.4%) | $7.02 M(+4.7%) |
| Jun 2018 | - | $1.58 M(-16.1%) | $6.71 M(-14.7%) |
| Mar 2018 | - | $1.89 M(+19.3%) | $7.87 M(-14.4%) |
| Dec 2017 | $9.19 M(+1.9%) | $1.58 M(-4.6%) | $9.19 M(-10.5%) |
| Sep 2017 | - | $1.66 M(-39.5%) | $10.26 M(+2.6%) |
| Jun 2017 | - | $2.74 M(-14.6%) | $10.00 M(-0.1%) |
| Mar 2017 | - | $3.21 M(+20.9%) | $10.01 M(+11.0%) |
| Dec 2016 | $9.02 M(-20.0%) | $2.66 M(+90.4%) | $9.02 M(+6.3%) |
| Sep 2016 | - | $1.39 M(-49.3%) | $8.49 M(-4.5%) |
| Jun 2016 | - | $2.75 M(+24.0%) | $8.89 M(-8.3%) |
| Mar 2016 | - | $2.22 M(+4.5%) | $9.69 M(-14.1%) |
| Dec 2015 | $11.27 M | $2.12 M(+18.3%) | $11.27 M(-2.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | $1.79 M(-49.4%) | $11.60 M(-8.6%) |
| Jun 2015 | - | $3.55 M(-6.7%) | $12.70 M(+11.1%) |
| Mar 2015 | - | $3.81 M(+55.2%) | $11.43 M(+12.4%) |
| Dec 2014 | $10.18 M(+192.7%) | $2.45 M(-15.1%) | $10.18 M(+20.1%) |
| Sep 2014 | - | $2.89 M(+26.4%) | $8.47 M(+32.1%) |
| Jun 2014 | - | $2.29 M(-10.3%) | $6.41 M(+25.9%) |
| Mar 2014 | - | $2.55 M(+241.2%) | $5.09 M(+46.4%) |
| Dec 2013 | $3.48 M(-22.8%) | $746.60 K(-10.1%) | $3.48 M(-39.2%) |
| Sep 2013 | - | $830.70 K(-14.0%) | $5.72 M(+1.9%) |
| Jun 2013 | - | $966.40 K(+3.6%) | $5.61 M(+14.9%) |
| Mar 2013 | - | $933.10 K(-68.8%) | $4.88 M(+8.3%) |
| Dec 2012 | $4.51 M(+52.3%) | $2.99 M(+313.6%) | $4.51 M(+0.8%) |
| Sep 2012 | - | $722.00 K(+203.5%) | $4.47 M(+19.2%) |
| Jun 2012 | - | $237.90 K(-57.5%) | $3.75 M(+6.7%) |
| Mar 2012 | - | $560.30 K(-81.0%) | $3.52 M(+18.8%) |
| Dec 2011 | $2.96 M(>+9900.0%) | $2.95 M(>+9900.0%) | $2.96 M(>+9900.0%) |
| Sep 2011 | - | $2400.00(-25.0%) | $15.30 K(-26.8%) |
| Jun 2011 | - | $3200.00(+28.0%) | $20.90 K(-6.7%) |
| Mar 2011 | - | $2500.00(-65.3%) | $22.40 K(-11.8%) |
| Dec 2010 | $25.40 K(+75.2%) | $7200.00(-10.0%) | $25.40 K(+0.8%) |
| Sep 2010 | - | $8000.00(+70.2%) | $25.20 K(+31.3%) |
| Jun 2010 | - | $4700.00(-14.5%) | $19.20 K(+16.4%) |
| Mar 2010 | - | $5500.00(-21.4%) | $16.50 K(+13.8%) |
| Dec 2009 | $14.50 K(-22.9%) | $7000.00(+250.0%) | $14.50 K(+8.2%) |
| Sep 2009 | - | $2000.00(0.0%) | $13.40 K(-0.7%) |
| Jun 2009 | - | $2000.00(-42.9%) | $13.50 K(-30.4%) |
| Mar 2009 | - | $3500.00(-40.7%) | $19.40 K(+3.2%) |
| Dec 2008 | $18.80 K(+3.9%) | $5900.00(+181.0%) | $18.80 K(-23.3%) |
| Sep 2008 | - | $2100.00(-73.4%) | $24.50 K(-6.1%) |
| Jun 2008 | - | $7900.00(+172.4%) | $26.10 K(+24.3%) |
| Mar 2008 | - | $2900.00(-75.0%) | $21.00 K(+16.0%) |
| Dec 2007 | $18.10 K(+3.4%) | $11.60 K(+213.5%) | $18.10 K(+29.3%) |
| Sep 2007 | - | $3700.00(+32.1%) | $14.00 K(-31.0%) |
| Jun 2007 | - | $2800.00(>+9900.0%) | $20.30 K(+16.0%) |
| Mar 2007 | - | $0.00(-100.0%) | $17.50 K(0.0%) |
| Dec 2006 | $17.50 K | $7500.00(-25.0%) | $17.50 K(+75.0%) |
| Sep 2006 | - | $10.00 K | $10.00 K |
FAQ
- What is Actinium Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals annual SGA year-on-year change?
- What is Actinium Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals quarterly SGA year-on-year change?
- What is Actinium Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals TTM SGA year-on-year change?
What is Actinium Pharmaceuticals annual SGA?
The current annual SGA of ATNM is $13.33 M
What is the all time high annual SGA for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high annual SGA is $13.33 M
What is Actinium Pharmaceuticals annual SGA year-on-year change?
Over the past year, ATNM annual SGA has changed by +$1.33 M (+11.10%)
What is Actinium Pharmaceuticals quarterly SGA?
The current quarterly SGA of ATNM is $2.83 M
What is the all time high quarterly SGA for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high quarterly SGA is $4.56 M
What is Actinium Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, ATNM quarterly SGA has changed by +$521.00 K (+22.59%)
What is Actinium Pharmaceuticals TTM SGA?
The current TTM SGA of ATNM is -$1.41 B
What is the all time high TTM SGA for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high TTM SGA is -$193.80 K
What is Actinium Pharmaceuticals TTM SGA year-on-year change?
Over the past year, ATNM TTM SGA has changed by -$1.42 B (-10681.47%)